CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.
Lin Y, Zhao Y, Chen M, Li Z, Liu Q, Chen J, Ding Y, Ding C, Ding Y, Qi C, Zheng L, Li J, Zhang R, Zhou J, Wang L, Zhang QQ.
Lin Y, et al. Among authors: zhang r, zhang qq.
BMC Cancer. 2023 May 26;23(1):479. doi: 10.1186/s12885-023-10974-4.
BMC Cancer. 2023.
PMID: 37237269
Free PMC article.